Literature DB >> 12615848

Predicting antiviral treatment response in chronic hepatitis C: how accurate and how soon?

Samuel S Lee1, Ayman A Abdo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12615848     DOI： 10.1093/jac/dkg135

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy.

Authors:  Claudia Monica Danilescu; Mihaela Ionescu; Daniela Larisa Sandulescu; Mihail Cristian Pirlog; Costin Teodor Streba; Ion Rogoveanu
Journal:  Diagnostics (Basel)       Date:  2022-05-09

2.  Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.

Authors:  Anne Boulestin; Nassim Kamar; Florence Legrand-Abravanel; Karine Sandres-Saune; Laurent Alric; Jean-Pierre Vinel; Lionel Rostaing; Jacques Izopet
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C.

Authors:  Baek Gyu Jun; Eui Ju Park; Woong Cheul Lee; Jae Young Jang; Soung Won Jeong; Young Don Kim; Gab Jin Cheon; Young Sin Cho; Sae Hwan Lee; Hong Soo Kim; Yun Nah Lee; Sang Gyune Kim; Young Seok Kim; Boo Sung Kim
Journal:  Korean J Intern Med       Date:  2018-03-14       Impact factor: 2.884

4.  Prediction of sustained virologic responses to combination therapy of pegylated interferon-α and ribavirin in patients with chronic hepatitis C infection.

Authors:  Mona H Ismail
Journal:  J Family Community Med       Date:  2013-01

5.  Dynamic interplay between CXCL levels in chronic hepatitis C patients treated by interferon.

Authors:  Abdel-Rahman N Zekri; Abeer A Bahnassy; Waleed S Mohamed; Hanaa M Alam El-Din; Hend I Shousha; Naglaa Zayed; Dina H Eldahshan; Ashraf Omar Abdel-Aziz
Journal:  Virol J       Date:  2013-07-01       Impact factor: 4.099
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.